Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

Title
Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
Authors
Keywords
-
Journal
GASTROENTEROLOGY
Volume 146, Issue 4, Pages 941-949.e2
Publisher
Elsevier BV
Online
2013-12-19
DOI
10.1053/j.gastro.2013.12.025

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now